Scholarlink

Background <p>Sex differences in <i>Mycobacterium tuberculosis</i> (Mtb) exposure likely contribute to sex differences in tuberculosis (TB) burden. However, population-level age- and sex-specific patterns of Mtb exposure among adolescents and adults have not been recently characterised in Malawi. We therefore conducted a cross-sectional survey to estimate age- and sex-specific Mtb immunoreactivity prevalence in Blantyre City, Malawi, and to assess whether prevalence diverges by sex with increasing age.</p> Methods <p>We used an open-access dataset of building footprints, known as Open Buildings, to obtain a random sample of households from 33 peri-urban neighbourhoods in Blantyre City. Adolescents and adults aged 10–40 years were recruited, participant characteristics recorded, and venous blood samples collected to determine Mtb immunoreactivity using the QuantiFERON-TB Gold Plus (QFT-Plus) assay. We fitted Bayesian multilevel logistic regression models to estimate the association between age, sex, and other risk factors with Mtb immunoreactivity, and compared predicted immunoreactivity prevalence across age-sex strata.</p> Results <p>Of 2833 participants, 40.0% (1133/2833) were male, the median age was 21 years (interquartile range: 16–28 years), and 8.7% (179/2047) self-reported living with HIV. Overall, 17.8% (503/2833) of participants were Mtb positive, Mtb immunoreactivity prevalence was 17.8% (95% credible interval [CrI]: 16.4–19.2%), corresponding to an annual risk of TB infection of 0.88% (95% CrI: 0.80%-0.95%). Prevalence was similar by sex among 10-19- and 30-40-year-olds. However, among 20-29-year-olds, prevalence was higher among males compared to females: 26.3% (95% CrI: 22.0%-30.8%) and 17.7% (95% CrI: 14.8%-20.8%), respectively. The annual risk of Mtb immunoreactivity conversion increased, on average, at a faster rate among males compared to females from age 10 years, peaking at 21 years, where it was 1.58 (95% CrI: 0.82–2.80) times higher among males compared to females. Tobacco smoking and alcohol drinking, more prevalent among males compared to females, were associated with increased immunoreactivity probability.</p> Conclusions <p>Adolescence appears to be a period of vulnerability for Mtb exposure, during which sex-specific vulnerabilities begin to emerge. Identifying the biological and social drivers of these vulnerabilities could inform targeted strategies to reduce sex disparities in TB.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Drivers of sex differences in Mycobacterium tuberculosis immunoreactivity among adolescents and adults in Blantyre, Malawi

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月23日

查看全文
  • Mphatso D Phiri,
  • Hannah M Rickman,
  • Hannah Mbale,
  • Helena RA Feasey,
  • Marriott Nliwasa,
  • Alvaro Schwalb,
  • Tisungane E Mwenyenkulu,
  • Kuzani N Mbendera,
  • Henry C Mwandumba,
  • Elizabeth L Corbett,
  • S Bertel Squire,
  • Marc YR Henrion,
  • Katherine C Horton,
  • Peter MacPherson

摘要

Background

Sex differences in Mycobacterium tuberculosis (Mtb) exposure likely contribute to sex differences in tuberculosis (TB) burden. However, population-level age- and sex-specific patterns of Mtb exposure among adolescents and adults have not been recently characterised in Malawi. We therefore conducted a cross-sectional survey to estimate age- and sex-specific Mtb immunoreactivity prevalence in Blantyre City, Malawi, and to assess whether prevalence diverges by sex with increasing age.

Methods

We used an open-access dataset of building footprints, known as Open Buildings, to obtain a random sample of households from 33 peri-urban neighbourhoods in Blantyre City. Adolescents and adults aged 10–40 years were recruited, participant characteristics recorded, and venous blood samples collected to determine Mtb immunoreactivity using the QuantiFERON-TB Gold Plus (QFT-Plus) assay. We fitted Bayesian multilevel logistic regression models to estimate the association between age, sex, and other risk factors with Mtb immunoreactivity, and compared predicted immunoreactivity prevalence across age-sex strata.

Results

Of 2833 participants, 40.0% (1133/2833) were male, the median age was 21 years (interquartile range: 16–28 years), and 8.7% (179/2047) self-reported living with HIV. Overall, 17.8% (503/2833) of participants were Mtb positive, Mtb immunoreactivity prevalence was 17.8% (95% credible interval [CrI]: 16.4–19.2%), corresponding to an annual risk of TB infection of 0.88% (95% CrI: 0.80%-0.95%). Prevalence was similar by sex among 10-19- and 30-40-year-olds. However, among 20-29-year-olds, prevalence was higher among males compared to females: 26.3% (95% CrI: 22.0%-30.8%) and 17.7% (95% CrI: 14.8%-20.8%), respectively. The annual risk of Mtb immunoreactivity conversion increased, on average, at a faster rate among males compared to females from age 10 years, peaking at 21 years, where it was 1.58 (95% CrI: 0.82–2.80) times higher among males compared to females. Tobacco smoking and alcohol drinking, more prevalent among males compared to females, were associated with increased immunoreactivity probability.

Conclusions

Adolescence appears to be a period of vulnerability for Mtb exposure, during which sex-specific vulnerabilities begin to emerge. Identifying the biological and social drivers of these vulnerabilities could inform targeted strategies to reduce sex disparities in TB.